0001104659-22-010535.txt : 20220201
0001104659-22-010535.hdr.sgml : 20220201
20220201204710
ACCESSION NUMBER: 0001104659-22-010535
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220129
FILED AS OF DATE: 20220201
DATE AS OF CHANGE: 20220201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schroeder Theodore R
CENTRAL INDEX KEY: 0001378690
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 22581112
MAIL ADDRESS:
STREET 1: 12481 HIGH BLUFF DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25-28 NORTH WALL QUAY
CITY: DUBLIN
STATE: L2
ZIP: D01 H104
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 414 COMMERCE DRIVE
STREET 2: STE 120
CITY: FORT WASHINGTON
STATE: PA
ZIP: 19034
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4
1
tm221371-11_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-01-29
0
0001641640
Nabriva Therapeutics plc
NBRV
0001378690
Schroeder Theodore R
414 COMMERCE DR.
SUITE 120
FORT WASHINGTON
PA
19034
1
1
0
0
Chief Executive Officer
Ordinary Shares
2022-01-29
4
F
0
10766
0.45
D
314736
D
Ordinary Shares
2022-01-31
4
F
0
125
0.48
D
314611
D
These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.
/s/ J. Christopher Naftzger, by power of attorney
2022-02-01